Lipopolysaccharide-Induced CXCL10 mRNA Level and Six Stimulant-mRNA Combinations in Whole Blood: Novel Biomarkers for Bortezomib Responses Obtained from a Prospective Multicenter Trial for Patients with Multiple Myeloma

• Takashi Watanabe ,

  * E-mail: takawata@komakihp.gr.jp

  Current address: Department of Hematology, Komaki City Hospital, Komaki, Japan

  Affiliation Hematology Division, National Cancer Center Hospital, Tokyo, Japan

  ⨯
• Masato Mitsuhashi,

  Affiliation Hitachi Chemical Research Center, Inc., Irvine, California, United States of America

  ⨯
• Morihiko Sagawa,

  Affiliation Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan

  ⨯
• Masaki Ri,

  Affiliation Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

  ⨯
• Kenshi Suzuki,

  Affiliation Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan

  ⨯
• Masahiro Abe,

  Affiliation Department of Hematology, Endocrinology and Metabolism Instutute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan

  ⨯
• Ken Ohmachi,

  Affiliation Division of Hematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan

  ⨯
• Yasunori Nakagawa,

  Affiliation Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan

  ⨯
• Shingen Nakamura,

  Affiliation Department of Hematology, Endocrinology and Metabolism Instutute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan

  ⨯
• Mizuki Chosa,

  Affiliation Hematology Division, National Cancer Center Hospital, Tokyo, Japan

  ⨯
• Shinsuke Iida,

  Affiliation Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

  ⨯
• Masahiro Kizaki

  Affiliation Department of Hematology, Saitama Medical Center, Saitama Medical University, Kawagoe, Japan

  ⨯